Paclitaxel: new insights into its regulation, biosynthesis and biotechnological production

The emergency to obtain effective substances against cancer, and the awareness to protect natural resources make plant biofactories a promising alternative for obtaining plant-derived compounds. In this context, the biotechnological production of the potent anticancer agent paclitaxel could be incre...

Full description

Bibliographic Details
Author: Escrich Montañana, Ainoa
Format: Doctoral thesis
Status:Published version
Publication date:2022
Country:España
Institution:CBUC, CESCA
Repository:TDR. Tesis Doctorales en Red
OAI Identifier:oai:www.tdx.cat:10803/687277
Online Access:http://hdl.handle.net/10803/687277
Access Level:Open access
Keyword:Biotechnological production
Gene regulation
Paclitaxel
Taxane biosynthesis
Taxus spp.
Biosíntesis de taxanos
Producción biotecnológica
Regulación genética
577
Description
Summary:The emergency to obtain effective substances against cancer, and the awareness to protect natural resources make plant biofactories a promising alternative for obtaining plant-derived compounds. In this context, the biotechnological production of the potent anticancer agent paclitaxel could be increased using in vitro cell cultures of Taxus spp. The objective of this work was to provide novel knowledge related to the biosynthesis and production of paclitaxel through the implementation of optimized Taxus spp. biofactories. Our results showed that: (1) The synergistic action of coronatine and calix[8]arene significantly increases the paclitaxel synthesis. (2) There exists an epigenetic control over the paclitaxel biosynthesis pathway, adversely affected in cultures maintained long-term under in vitro conditions. (3) By increasing the level of ploidy in Taxus spp. cell cultures, the production of taxanes also increased. (4) The enzyme TB574 is the ideal candidate to carry out the hydroxylation step on the C1 carbon of the taxane skeleton.